#$%^&*AU2018271231A120181213.pdf#####ABSTRACT The present invention relates to 1,2,4-oxadiazole and 1,2,4-thiadiazole compounds as therapeutic agents capable of inhibiting the programmed cell death 1 (PDi) signaling pathway. The invention also refers to derivatives of the therapeutic 5 agents. The invention also encompasses the use of the said therapeutic agents and derivatives for treatment of disorders via immunopotentiation comprising inhibition of immunosuppressive signal induced due to PD-1, PD-Li, or PD-L2 and therapies using them. 1